Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
2.880
-0.350 (-10.84%)
Nov 17, 2026, 3:37 PM EST - Market open
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $238.42 million as of November 17, 2026. It is the 18,577th most valuable company in the world and the 3,256th biggest in the United States. Its market cap has decreased by 63.87% in one year.
Market Cap
238.42M
Enterprise Value
49.89M
1-Year Change
-63.87%
Global Rank
Country Rank
#3,256 United States
Category
ChartMarket Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $238.42M, a decrease of -12.14%. That is a compound annual growth rate of -4.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 238.42M | -67.10% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clinuvel Pharmaceuticals | 253.61M |
| Vogenx | 247.63M |
| vTv Therapeutics | 245.01M |
| Vanda Pharmaceuticals | 241.27M |
| Arcturus Therapeutics Holdings | 240.96M |
| Immuneering | 240.27M |
| Camp4 Therapeutics | 238.47M |
| Bicycle Therapeutics | 236.22M |